Citations

Clear

6273 citation(s) found for "To, Andrew".

PSYCHOGENIC TREMOR OCCURRING AFTER DEEP BRAIN STIMULATION SURGERY FOR ESSENTIAL TREMOR
McKeon, Andrew , Ahlskog, J. Eric , Matsumoto, Joseph Y., McKeon, Andrew

Mayo Clinic

Neurology | May 4, 2008 | Volume: 70 | Issue: 16_part_2 | Pages: 1498-1499

10.1212/01.wnl.0000310429.30886.bc | PMID 18413577 Get It

Dual-Energy CT Iodine-Subtraction Virtual Unenhanced Technique to Detect Urinary Stones in an Iodine-Filled Collecting System: A Phantom Study
Takahashi, Naoki , Hartman, Robert P. , Vrtiska, Terri J., Primak, Andrew N. , Dzyubak, O. P. , Mandrekar, Jayawant N. , Kawashima, Akira , Fletcher, Joel G. , McCollough, Cynthia H. , Takahashi, Naoki

Mayo Clinic

American Journal of Roentgenology | April 22, 2008 | Volume: 190 | Issue: 5 | Pages: 1169-1173

10.2214/ajr.07.3154 | PMID 18430827 Get It

Impact of Time of Presentation on the Care and Outcomes of Acute Myocardial Infarction
Jneid, Hani , Fonarow, Gregg C. , Cannon, Christopher P. , Palacios, Igor F. , Kılıç, Teoman , Moukarbel, George V. , Maree, Andrew , LaBresh, Kenneth A. , Newby, L. Kristin , Fletcher, Gerald F., Wexler, Laura, Li, Liang , Peterson, Eric D.

Mayo Clinic

Circulation | April 22, 2008 | Volume: 117 | Issue: 19 | Pages: 2502-2509

10.1161/circulationaha.107.752113 | PMID 18427127 Get It

Background— Prior studies have demonstrated an inconsistent association between patients’ arrival time for acute myocardial infarction (AMI) and their subsequent medical care and outcomes. Methods and Results— Using a contemporary national clinical registry, we examined differences in medical care and in-hospital mortality among AMI patients admitted during regular hours (weekdays 7 am to 7 pm ) versus off-hours (weekends, holidays, and 7 pm to 7 am weeknights). The study cohort included 62 814 AMI patients from the Get With the Guidelines–Coronary Artery Disease database admitted to 379 hospitals throughout the United States from July 2000 through September 2005. Overall, 33 982 (54.1%) patients arrived during off-hours. Compared with those arriving during regular hours, eligible off-hour patients were slightly less likely to receive primary percutaneous coronary intervention (adjusted odds ratio [OR], 0.93; 95% confidence interval [CI], 0.89 to 0.98), had longer door-to-balloon times (median, 110 versus 85 minutes; P <0.0001), and were less likely to achieve door-to-balloon ≤90 minutes (adjusted OR, 0.34; 95% CI, 0.29 to 0.39). Arrival during off-hours was associated with slightly lower overall revascularization rates (adjusted OR, 0.94; 95% CI, 0.90 to 0.97). No measurable differences, however, were found in in-hospital mortality between regular hours and off-hours in the overall AMI, ST-elevated MI, and non–ST-elevated MI cohorts (adjusted OR, 0.99; 95% CI, 0.93 to 1.06; adjusted OR, 1.05; 95% CI, 0.94 to 1.18; and adjusted OR, 0.97; 95% CI, 0.90 to 1.04, respectively). Similar observations were made across most age and sex subgroups and with an alternative definition for arrival time (weekends/holidays versus weekdays). Conclusions— Despite slightly fewer primary percutaneous coronary interventions and overall revascularizations and significantly longer door-to-balloon times, patients presenting with AMI during off-hours had in-hospital mortality similar to those presenting during regular hours.
Long-Term Outcomes of Percutaneous Nephrolithotomy Compared to Shock Wave Lithotripsy and Conservative Management
Krambeck, Amy E. , LeRoy, Andrew J., Patterson, David E., Gettman, Matthew T.

Mayo Clinic

Journal of Urology | April 19, 2008 | Volume: 179 | Issue: 6 | Pages: 2233-2237

10.1016/j.juro.2008.01.115 | PMID 18423676 Get It

Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial
Cho, Nancy L. , Redston, Mark , Carothers, Adelaide M., Hornick, Jason L. , Wilton, Andrew S. , Sontag, Stephen J. , Nishioka, Norman S., Giardiello, Francis M., Saltzman, John R. , Gostout, Chris, Eagle, Craig, Hawk, Ernest T. , Zauber, Ann Graham , Bertagnolli, Monica M. , Hornick, Jason L

Mayo Clinic

Cancer Prevention Research | April 14, 2008 | Volume: 1 | Issue: 1 | Pages: 21-31

10.1158/1940-6207.capr-07-0011 | PMID 19138933 Get It

Abstract Aberrant crypt foci (ACF) are the earliest visible neoplastic lesions in the colorectum. The natural history of these lesions and their role in the adenoma-carcinoma sequence are unknown. We studied ACF in a subset of patients randomized to placebo (n = 17), celecoxib (200 mg twice daily; n = 15), or celecoxib (400 mg twice daily; n = 13) in the Adenoma Prevention with Celecoxib (APC) trial. Magnification chromoendoscopy was done to identify, count, and biopsy ACF within the rectum at baseline and after 8 to 12 months of treatment. A total of 655 ACF were identified in 45 patients. We examined 70 of these ACF histologically, and all 70 were nondysplastic. Cohort characteristics and APC trial treatment results for substudy patients were similar to those of the overall APC trial. There was no significant modulation of ACF by celecoxib (versus placebo; P = 0.77). Immunohistochemical comparison of ACF with adjacent normal mucosa showed that ACF had an increased proliferative index as determined by Ki-67 (P &lt; 0.0001), but lacked other features of neoplasia such as increased cyclooxygenase-2 expression and microvessel density, nuclear localization of β-catenin, or decreased expression of the tumor suppressors SMAD4, Estrogen Receptor α, or MGMT. Only baseline SMAD4 expression in ACF correlated with posttreatment adenoma recurrence (independent of treatment arm; P = 0.01). The presence or number of nondysplastic ACF did not correlate with a higher risk of synchronous advanced or recurrent adenomas. Our overall results indicated that nondysplastic ACF were not accurate surrogate endpoint biomarkers of recurrent colorectal adenomas in the APC trial.
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
Borowitz, Michael J., Carroll, Andrew J. , Carroll, William L. , Linda, Stephen B., Martin, Paul L. , Pullen, DJ, Viswanatha, David S., Camitta, Bruce M., Devidas, Meenakshi , Hunger, Stephen P. , Bowman, W. Paul , Willman, Cheryl L. , Winick, Naomi Joan

Mayo Clinic

Blood | April 4, 2008 | Volume: 111 | Issue: 12 | Pages: 5477-5485

10.1182/blood-2008-01-132837 | PMID 18388178 Get It

Abstract Minimal residual disease (MRD) is an important predictor of relapse in acute lymphoblastic leukemia (ALL), but its relationship to other prognostic variables has not been fully assessed. The Children's Oncology Group studied the prognostic impact of MRD measured by flow cytometry in the peripheral blood at day 8, and in end-induction (day 29) and end-consolidation marrows in 2143 children with precursor B-cell ALL (B-ALL). The presence of MRD in day-8 blood and day-29 marrow MRD was associated with shorter event-free survival (EFS) in all risk groups; even patients with 0.01% to 0.1% day-29 MRD had poor outcome compared with patients negative for MRD patients (59% ± 5% vs 88% ± 1% 5-year EFS). Presence of good prognostic markers TEL-AML1 or trisomies of chromosomes 4 and 10 still provided additional prognostic information, but not in National Cancer Insitute high-risk (NCI HR) patients who were MRD+. The few patients with detectable MRD at end of consolidation fared especially poorly, with only a 43% plus or minus 7% 5-year EFS. Day-29 marrow MRD was the most important prognostic variable in multi-variate analysis. The 12% of patients with all favorable risk factors, including NCI risk group, genetics, and absence of days 8 and 29 MRD, had a 97% plus or minus 1% 5-year EFS with nonintensive therapy. These studies are registered at www.clinicaltrials.gov as NCT00005585, NCT00005596, and NCT00005603.
Idiopathic Nonspecific Interstitial Pneumonia
Hunninghake, Gary W., King, Talmadge E. , Lynch, David A. , Colby, Thomas V. , Galvin, Jeffrey R. , Brown, Kevin M. , Chung, Man Pyo , Cordier, Jean-François, Bois, Roland M. du, Flaherty, Kevin R., Franks, Teri J. , Hansell, David M., Hartman, Thomas E. , Kazerooni, Ella A. , Kim, Dong Soon, Kitaichi, Masanori, Koyama, Takashi , Nagai, Sonoko, Midthun, David E. , Müller, Nestor L., Raghu, Ganesh , Selman, Moisés , Wells, Athol U. , Travis, William D. , Flaherty, Kevin R., Martínez, Fernando J. , Nicholson, Andrew G.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 3, 2008 | Volume: 177 | Issue: 12 | Pages: 1338-1347

10.1164/rccm.200611-1685oc | PMID 18388353 Get It

Abstract Rationale The 2002 American Thoracic Society/European Respiratory Society classification of idiopathic interstitial pneumonias identified nonspecific interstitial pneumonia (NSIP) as a provisional diagnosis. Concern was expressed that NSIP was a “wastebasket” category, difficult to distinguish from other idiopathic interstitial pneumonias. Objectives The following questions were addressed: (1) Is idiopathic NSIP a distinct entity? 2) If so, what are its clinical, radiologic and pathologic characteristics? (3) What is the role of radiology and pathology in establishing the diagnosis? (4) To make a diagnosis of idiopathic NSIP, what other disorders need to be excluded and how should this be done? Methods Investigators who had previously reported cases of idiopathic NSIP were invited to submit cases for review (n = 305). After initial review, cases with complete clinical, radiologic, and pathologic information (n = 193) were reviewed in a series of workshops. Measurements and Main Results Sixty-seven cases were identified as NSIP. Mean age was 52 years, 67% were women, 69% were never-smokers, and 46% were from Asian countries. The most common symptoms were dyspnea (96%) and cough (87%); 69% had restriction. By high-resolution computed tomography, the lower lung zones were predominantly involved in 92% of cases; 46% had a peripheral distribution; 47% were diffuse. Most showed a reticular pattern (87%) with traction bronchiectasis (82%) and volume loss (77%). Lung biopsies showed uniform thickening of alveolar walls with a spectrum of cellular to fibrosing patterns. Five-year survival was 82.3%. Conclusions Idiopathic NSIP is a distinct clinical entity that occurs mostly in middle-aged women who are never-smokers. The prognosis of NSIP is very good.
Computer-Aided Design, Manufacturing, and Modeling of Polymer Scaffolds for Tissue Engineering
Stone, J.J., Thoreson, Andrew R. , Langner, Kurt L., Norton, Jay M., Stone, D.J. , Wang, Francis W., O’Driscoll, Shawn W. , An, Kai‐Nan , Langner, Kurtis L., Fitzsimmons, James S

Mayo Clinic

Manufacturing Engineering and Materials Handling, Parts A and B | April 3, 2008 | Volume: No volume available | Issue: No issue available | Pages: 169-174

10.1115/imece2005-81621 Get It

A custom computer-controlled rapid prototyping system was designed and developed in this research. This system for bio-manufacturing of polymer scaffolds included 3D motion control components, a nozzle, a pressure controller, and a temperature-controlled reservoir containing a biomaterial. Heating elements built into the reservoir melted the biomaterial. The pressure line attached to the reservoir provided a controllable force that extruded the polymer biomaterial through the nozzle and deposited the polymer biomaterial onto a platform to fabricate scaffolds. A low pressure (830 KPa) system was designed and fabricated to accommodate different temperatures, motion speeds, and viscosities of polymer biomaterials. The reservoir with the nozzle was mounted to servo motor-controlled linear x-y motion devices along with a third servo motor-controlled device that controlled the z-position of the platform. Poly(ε-caprolactone) [PCL] was used to fabricate scaffolds with designed structure that were used in cell and tissue regeneration studies. 3D computer-aided design (CAD) with Pro-Engineer and computational finite element analysis (FEA) programs with MSC_Patran and MSC_Marc were used to model scaffold designs with appropriate architecture and material selection. The CAD models were used in FEA to develop new methods for determining mechanical properties of tissue scaffolds of desired structure and geometry. FEA models were validated by mechanical testing and other published results. Technology developed in this research has potential for the advancement of bio-manufacturing, and design optimization of scaffolds for tissue engineering.
Is a Pattern of Increasing Biomarker Concentrations Important for Long-Term Risk Stratification in Acute Coronary Syndrome Patients Presenting Early after the Onset of Symptoms?
Kavsak, Peter A. , Newman, Alice, Ko, Dennis T. , Lustig, Viliam, MacRae, Andrew R., Jaffe, Allan S. , Richards, C. Sue , Jaffe, Allan S. , Kavsak, Peter

Mayo Clinic

Clinical Chemistry | March 28, 2008 | Volume: 54 | Issue: 4 | Pages: 747-751

10.1373/clinchem.2007.094664 | PMID 18375487 Get It

Abstract Background: Guidelines for treatment of acute coronary syndrome (ACS) recommend observing a rise or fall in cardiac troponin (cTn) concentrations for assessing acute injury. It is unknown whether a rising pattern presages a more adverse long-term prognosis than elevations that do not change. The present study assessed whether a rising pattern of cardiac biomarkers was more prognostic than simple elevations. Methods: We measured N-terminal pro-brain natriuretic peptide (NT-proBNP) (Roche), cTnT (Roche) and cTnI (Beckman Coulter) in 212 ACS patients. These biomarkers were measured in coincident EDTA and heparin plasma samples available from at least 2 different time points, an early first specimen obtained a median of 2 hours after onset of symptoms, interquartile range (IQR) 2–4 hours, and a later second specimen obtained at 9 hours, IQR 9–9 hours. The cTn concentration in the second specimen was used to classify myocardial necrosis (cTnI &gt;0.04 ug/L; cTnT &gt;0.01 ug/L). Outcomes [death, myocardial infarction (MI), heart failure (HF)] were obtained &gt;8 years after the initial presentation. For patients with myocardial necrosis and a cTn concentration ratio (second/first measured concentrations) ≥1.00, the concentration ratios and the absolute concentrations in the second specimen were used to assess prognosis after 4 years. Results: In myocardial necrosis, the relative change (cTn2/cTn1) was greater for cTnI than for cTnT (P &lt;0.01), whereas the relative change in NT-proBNP was the same regardless of which troponin was used to classify necrosis (P = 0.71). The concentration ratio for cTnI, cTnT, and NT-proBNP was not useful for risk stratification (i.e., death/MI/HF; P ≥0.15). Conclusions: A rise in cardiac troponin or NT-proBNP concentration in ACS patients presenting early after onset of pain is not helpful for long-term prognosis.
Whole Genome Analyses Suggest Ischemic Stroke and Heart Disease Share an Association With Polymorphisms on Chromosome 9p21
Matarín, Mar, Brown, W. Mark , Singleton, Andrew , Hardy, John , Meschia, James F. , Hardy, John

Mayo Clinic

Stroke | March 15, 2008 | Volume: 39 | Issue: 5 | Pages: 1586-1589

10.1161/strokeaha.107.502963 | PMID 18340101 Get It

Background and Purpose— Recently independent studies reported an association between coronary heart disease and single-nucleotide polymorphisms (SNPs) located at chromosome 9p21, near CDKN2A and CDKN2B genes. Given that stroke is a common complication after myocardial infarction, we investigated if the same SNPs were associated with ischemic stroke in our population. Methods— We recently initiated a whole genome analysis of ischemic stroke and published the first stage of a case control study using >400 000 SNPs from Illumina Infinium Human-1 and HumanHap300 assays. We focused on SNPs recently associated with heart disease by Helgadottir and colleagues and SNPs from the same haplotype block. Results— In analyses both unadjusted and adjusted for stroke risk factors, significant associations with ischemic stroke were observed for SNPs from the same haplotype block previously associated with myocardial infarction. Significant association was also seen between disease and haplotypes involving these SNPs, both with and without adjustment for stroke risk factors (odd ratios: 1.01 to 2.65). Conclusions— These data are important for 3 reasons: first, they suggest a genetic association for stroke; second, they suggest that this association shares pathogenic mechanisms with heart disease and diabetes; and third, they illustrate, that public release of data can facilitate rapid risk locus discovery.